ANTHENATAL MYOCARDITISES OF CHILDREN
Abstract
Anthenatal myocarditises develop in the period of pre-natal development of fetus. The leading role in their genesis is played by somatic diseases of expectant mother, placenta permeability disorder, mother and fetus immunity reduction, fetus pre-natal hypoxia. Fibro-elastosis or elasto-fibrosis is a compulsory morphological substrate. This is associated with the specific feature of the fetus response to the action of an inflammatory agent to the 7th month of gestation. During the mentioned period, fetus tissues cannot exhibit a classical inflammation reaction. As a result, a diffuse thickening of endocardium formed by collagen or elastic tissue is seen in the majority of fetuses. Owing to this fact, the presence of fibro-elastosis or elasto-fibrosis is a marker of early anthenatal myocarditis. At late congentinal myocarditis, a normal inflammatory reaction occurs.
The article presents the modern concepts of congentinal myocarditises of children, as well as the considerations of ethiology and clinical implications of early and late anthenatal myocarditises of children. The basic approaches to the detection, differential diagnosis and treatment of disease depending on the period of fetus infection are described.
About the Authors
L. I. Viazova
Belаrusian Statе Medical University, Minsk
Belarus
Belarus
Ph. D. (Med.), Assistant Professor
83, Dzerzhynskiy Ave., 220116
A. N. Bashlakova
Belаrusian Statе Medical University, Minsk
Belarus
Belarus
Ph. D. (Med.), Assistant Professor
83, Dzerzhynskiy Ave., 220116
References
1. Belokon’ N. A., Kuberger M. B. Diseases of the heart and blood vessels in children: a guide for doctors: in 2 vol. Мoscow, Meditsina Publ., 1987. Vol. 2 (in Russian).
2. Belozerov Yu. M. Pediatric cardiology. Мoscow, MEDpress-inform Publ., 2004. 600 p. (in Russian).
3. Mutaf’ian O. A. Carditis in children and adolescents. St. Petersburg, SPbMAPO Publ., 2006. 288 p. (in Russian).
4. Belyaeva L. M. , Khrustaleva E. K. Cardiovascular diseases in children and adolescents. Minsk, Vyshejshaja shkola Publ., 2003. 364 p. (in Russian).
5. Tereshchenko S. N., Arutyunov G. P., Giliarevskii S. R. Clinical recommendations for the diagnosis and treatment of myocarditis. Evraziiskii kardiologicheskii zhurnal [Eurasian Cardiology Journal], 2015, no. 3, pp. 3–17 (in Russian).
6. Japanese Circulation Society (JCS) Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009). Circulation Journal, 2011, no. 75, pp. 734–743.
7. Rose N. R. Myocarditis: infection versus autoimmunity. Clinical Immunology, 2009, vol. 29, no. 6, pp. 730–737. DOI: 10.1007/s10875–009–9339-z
8. Shabalov N. P. Children’s diseases, in 2 vol., 6th ed. St. Petersburg, Piter Publ., 2011, vol. 2, pp. 49–52 (in Russian).
9. Ivkina S. S., Zariankina A. I. Non-rheumatic carditis in children. Gomel, Gomel’skii gosudarstvennyi meditsinskii universitet Publ., 2012. 24 p. (in Russian).
10. Kühl U., Lassner D., von Schlippenbach J., Poller W., Schultheiss H. P. Interferon-beta improves survival in enterovirus-associated cardiomyopathy. Journal of the American College of Cardiology, 2012, no. 60, pp. 1295–1296. DOI: 10.1016/j. jacc.2012.06.026
11. Cooper L. T., Baughman K. L., Feldman A. M., Frustaci A., Jessup M., Kuhl U., Levine G. N., Narula J., Starling R. C., Towbin J., Virmani R. The role of endomyocardial biopsy in the management of cardiovascular disease : a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. European Heart Journal, 2007, vol. 28, no. 24, pp. 3076–3093. DOI: 10.1016/j.jacc.2007.09.008
12. Sadykova D. I., Arkhipova N. N. Non-rheumatic carditis. Prakticheskaya meditsina [Practical Medicine], 2010, no. 5, pp. 55–60 (in Russian).
13. Yoshikawa, T., Baba A., Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy. Circulation Journal, 2009, vol. 73, no. 4, pp. 602–607.
14. Practical guidance on childhood diseases. Vol. 3: Cardiology and rheumatology of childhood. Ed. by G. A. Samsygina, M. Yu. Shcherbakova. Мoscow, Medpraktika-M Publ., 2009. 812 p. (in Russian).
15. Dennert R., Crijns H. J., Heymans S. Acute viral myocarditis. European Heart Journal, 2008, vol. 29, no. 17, pp. 2073–2082. DOI: 10.1093/eurheartj/ehn296
16. Kindermann I., Kindermann M., Kandolf R., Klingel K., Bültmann B., Müller T., Lindinger A., Böhm M. Predictors of outcome in patients with suspected myocarditis. Circulation, 2008, vol. 118, no. 6, pp. 639–648. DOI: 10.1161/ CIRCULATIONAHA.108.769489
17. Kotlukova N. P., Khuzina O. M., Nemirovskii V. B., Matiunina E. A. Fetal and neonatal disorders of cardiac rhythm and conduction. Pediatrics, 2007, vol. 86, no. 2, pp. 5–12 (in Russian).
18. Ukena C., Mahfoud F., Kindermann I., Kandolf R., Kindermann M., Böhm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. European Journal of Heart Failure, 2011, no. 13, pp. 398–405. DOI: 10.1093/ eurjhf/hfq229
19. Kir’ianova N. V., Babushkina G. D., Mikhailovskaya L. V., Borodina E. N., Babushkina L. V., Kir’ianova T. V., Shavrin A. P. Difficulties in diagnosing nonrheumatic myocarditis. Clinical observation. Perm Medical Journal, 2016, vol. 33, no. 1, pp. 103–110 (in Russian).
20. Beliaeva L. M., Voitova E. V., Kozharskaya L. G., Kolupaeva E. A., Korol’ S. M., Malevanaya I. A., Mikul’chik N. V., Khrustaleva E. K., Chizhevskaya I. D. Pediatrics. Мoscow, Meditsinskaya literatura Publ., 2011. 568 p. (in Russian).
21. Kaya, Z., Katus H. A., Rose N. R. Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clinical Immunology, 2010, vol. 134, no. 1, pp. 80–88. DOI: 10.1016/j.clim.2009.04.008
22. Staudt A., Herda L. R., Trimpert C., Lubenow L., Landsberger M., Dörr M., Hummel A., Eckerle L. G., Beug D., Müller C., Hoffmann W., Weitmann K., Klingel K., Kandolf R., Kroemer H. K., Greinacher A., Felix S. B. Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy. Clinical Pharmacology & Therapeutics, 2010, vol. 87, no. 4, pp. 452–458. DOI: 10.1038/clpt.2009.246
23. Mahfoud F., Gärtner B., Kindermann M., Ukena C., Gadomski K., Klingel K., Kandolf R., Böhm M., Kindermann I. Virus serology in patients with suspected myocarditis: utility or futility? European Heart Journal, 2011, vol. 32, no. 7, pp. 897– 903. DOI: 10.1093/eurheartj/ehq493
24. She R. C., Hammond E. H. Utility of immunofluorescence and electron microscopy in endomyocardial biopsies from patients with unexplained heart failure. Cardiovascular Pathology, 2010, vol. 19, no. 4, pp. 99–105. DOI: 10.1016/j.carpath.2009.04.004
25. Caforio A. L., Calabrese F., Angelini A., Tona F., Vinci A, Bottaro S., Ramondo A., Carturan E., Iliceto S., Thiene G., Daliento L. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. European Heart Journal, 2007, vol. 28, no. 11, pp. 1326–1333. DOI: 10.1093/eurheartj/ehm076
26. Andreoletti L., Lévêque N., Boulagnon C., Brasselet C., Fornes P. Viral causes of human myocarditis. Archives of Cardiovascular Diseases, 2009, vol. 102, no. 6/7, pp. 559–568. DOI: 10.1016/j.acvd.2009.04.010
27. Cooper L. T. Myocarditis. New England Journal of Medicine, 2009, vol. 360, pp. 1526–1538. DOI: 10.1056/ NEJMra0800028
Review
For citations:
Viazova L.I., Bashlakova A.N. ANTHENATAL MYOCARDITISES OF CHILDREN. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2017;(4):111-119. (In Russ.)
Views: 844
Email this article 